The Horse

MAR 2018

The Horse:Your Guide To Equine Health Care provides monthly equine health care information to horse owners, breeders, veterinarians, barn/farm managers, trainer/riding instructors, and others involved in the hands-on care of the horse.

Issue link: https://thehorse.epubxp.com/i/936432

Contents of this Issue

Navigation

Page 74 of 115

Adequan ® i.m. (Brand of Polysulfated Glycosaminoglycan (PSGAG) INDICATIONS For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. IMPORTANT SAFETY INFORMATION There are no known contraindications to the use of intramuscular Adequan ® i.m. brand Polysulfated Glycosaminoglycan in horses. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. Please see Full Prescribing Information at www.adequan.com . The veterinarians at Littleton Equine Medical Center have been committed to making a difference for the horse since 1950. Over the years, Adequan ® i.m. has earned its place in their practice. Only Adequan ® REVERSES the disease cycle, REPAIRS cartilage, RESTORES joint lubrication and REDUCES inflammation to help keep joints moving and horses performing. 1, 2 Adequan ® and the Horse Head design are registered trademarks of Luitpold Pharmaceuticals, Inc. © Luitpold Animal Health, division of Luitpold Pharmaceuticals, Inc. 2017. PP-AI-US-0086 Iss. 12/2017 Three generations 1 Adequan ® i.m. [package insert]. Shirley, NY: Luitpold Animal Health; 2008. 2 Burba DJ, Collier MA, DeBault LE, Hanson-Painton O, Thompson HC, Holder CL: In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondral defect model. J Equine Vet Sci 1993; 13: 696-703. 3 McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res 2012; 1: 297-309. 4 McIlwraith CW, Frisbie DD, Kawcak CE, van Weeren PR. Joint Disease in the Horse. St. Louis, MO: Elsevier, 2016; 33-48

Articles in this issue

Links on this page

Archives of this issue

view archives of The Horse - MAR 2018